Generalized Anxiety Disorder (characterized by pervasive and persistent anxiety that is not confined to, or predominantly associated with, any specific external situation, also known as "free-floating anxiety". The following chief complaints are common: persistent nervousness, tremors, muscle tension, sweating, light-headedness, palpitations, dizziness, and epigastric discomfort. The course of ill
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subjects who have signed the main trial informed consent form and have received at least one dose of the investigational product during or within the main trial period; 2.Be capable of fully understanding and signing the informed consent form for this extended observational study. 3.Subjects shall have no contraindications to venous blood collection, exhibit normal coagulation function, and be able to cooperate with the additional blood collection procedures scheduled at each visit.
Exclusion criteria
Exclusion criteria: 1.Subjects who have seriously violated the protocols of both the main trial and this observational study; 2.Subjects with severe anemia or coagulation disorders; 3.Other conditions judged by the investigator to render the subject ineligible for enrollment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adrenocorticotropic Hormone;Plasma levels of Corticotropin-Releasing Factor;Cortisol levels;Omics-related indicators; | — |
Countries
China
Contacts
Beijing Anding Hospital Affiliated to Capital Medical University